PAHC

Phibro Animal Health Corporation

PAHC.US pahc.com + Research + Basket
CIK 0001069899
Employees 2,605
Phone 201 329 7300
Fiscal year end June
IPO Apr 11, 2014
Address Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
38.89
+0.03 (+0.08%)
USD · NASDAQ
52-week range
28.04
59.64
Trading at 34% of the 52-week range
Market Cap
1.58B
P/E Ratio
15.99
Forward P/E
13.83
Book Value
9.50
Div. Yield
1.27%
% Institutions
102.78%
% Insiders
0.878%

1 Year

-6.0%

3 Year

+279.6%

10 Year

+83.2%
Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Actions

Add an action for PAHC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Jack Clifford Bendheim Executive Chairman 1947
Mr. Daniel M. Bendheim J.D. CEO, President & Director 1972
Mr. Glenn C. David Chief Financial Officer 1972
Mr. Larry L. Miller Chief Operating Officer 1964
Ms. Judith A. Weinstein Senior VP, General Counsel & Corporate Secretary 1969
Mr. Jonathan Bendheim Executive VP of Talent, Technology and Business Development & Director 1976
Ms. Lisa Ann Escudero Senior Vice President of Human Resources 1962
Mr. Ramon Fuenmayor President South America Region NA
Mr. Samson Li President of Asia Pacific Region 1972
Mr. Todd Armstrong President of North American Region NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 22, 2026 Jack Bendheim N/A Sale 7.04K $54.29 $382.20K SEC
Apr 16, 2026 Jack Bendheim N/A Sale 7.04K $54.64 $384.67K SEC
Apr 14, 2026 Jack Bendheim N/A Sale 7.04K $59.08 $415.92K SEC
Mar 19, 2026 Jack Bendheim N/A Sale 7.04K $52.52 $369.74K SEC
Mar 18, 2026 Jack Bendheim N/A Sale 10.56K $52.68 $556.30K SEC
Mar 17, 2026 Jack Bendheim N/A Sale 5.28K $51.66 $272.76K SEC
Mar 13, 2026 Jack Bendheim N/A Sale 5.28K $48.91 $258.24K SEC
Feb 26, 2026 Jack Bendheim N/A Sale 7.04K $53.73 $378.26K SEC
Feb 24, 2026 Jack Bendheim N/A Sale 7.04K $51.37 $361.64K SEC
Feb 20, 2026 Jack Bendheim N/A Sale 7.04K $51.42 $362.00K SEC
Feb 18, 2026 Jack Bendheim N/A Sale 7.04K $51.40 $361.86K SEC
Feb 13, 2026 Jack Bendheim N/A Sale 7.04K $51.96 $365.80K SEC
Feb 11, 2026 Jack Bendheim N/A Sale 14.18K $51.62 $732.18K SEC
Feb 10, 2026 Jack Bendheim N/A Sale 58.01K $51.81 $3.01M SEC
Feb 05, 2026 Jack Bendheim N/A Sale 110.84K $48.38 $5.36M SEC
Feb 04, 2026 Jack Bendheim N/A Sale 3.52K $41.15 $144.85K SEC
Feb 03, 2026 Jack Bendheim N/A Sale 9.66K $41.47 $400.60K SEC
Jan 30, 2026 Jack Bendheim N/A Sale 6.69K $40.09 $268.32K SEC
Jan 29, 2026 Jack Bendheim N/A Sale 6.77K $40.12 $271.69K SEC
Jan 23, 2026 Jack Bendheim N/A Sale 1.24K $40.55 $50.08K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.22M Jun 30, 2026 7.93% $0.00 -1.07%
FMR Inc 3.16M Jun 30, 2026 7.78% $0.00 45.43%
State Street Corp 1.04M Jun 30, 2026 2.56% $0.00 9.30%
Millennium Management LLC 936.70K Jun 30, 2026 2.31% $0.01 1,578.10%
Vanguard Capital Management, LLC 923.32K Jun 30, 2026 2.27% $0.00 3.59%
Geode Capital Management, LLC 657.35K Jun 30, 2026 1.62% $0.00 8.72%
Lord, Abbett & Co LLC 653.31K Jun 30, 2026 1.61% $0.06 64.27%
Dimensional Fund Advisors, Inc. 531.09K Jun 30, 2026 1.31% $0.00 4.58%
Vanguard Portfolio Management, LLC 508.49K Jun 30, 2026 1.25% $0.00 3.70%
Renaissance Technologies Corp 480.50K Jun 30, 2026 1.18% $0.02 -16.69%
CastleKnight Management LP 461.32K Jun 30, 2026 1.14% $0.20 507.84%
Morgan Stanley - Brokerage Accounts 412.63K Jun 30, 2026 1.02% $0.00 5.48%
Dana Investment Advisors Inc 387.87K Jun 30, 2026 0.96% $0.32 34.81%
Amvescap Plc. 336.33K Jun 30, 2026 0.83% $0.00 1.62%
Nuveen, LLC 314.08K Jun 30, 2026 0.77% $0.00 -31.11%
Oberweis Asset Management Inc 311.10K Jun 30, 2026 0.77% $0.20 12.27%
Ranger Investment Management LP 292.41K Jun 30, 2026 0.72% $0.58 5.00%
Charles Schwab Investment Management Inc 260.86K Jun 30, 2026 0.64% $0.00 -1.29%
Bank of New York Mellon Corp 254.38K Jun 30, 2026 0.63% $0.00 10.60%
Allspring Global Investments Holdings, LLC 254.23K Jun 30, 2026 0.63% $0.01 -11.16%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 1.25M 3.09% ▲ 0.03% Sep 30, 2026
2 Fidelity Low-Priced Stock 792.40K 1.95% ▲ 0.66% Jul 31, 2026
3 Vanguard MStar Total Stk Mkt Idx Invest 659.63K 1.62% ▲ 0.00% Sep 30, 2026
4 iShares Russell 2000 ETF 551.54K 1.36% ▼ 1.14% Sep 30, 2026
5 Strategic Advisers Fidelity US TtlStk 405.24K 1.00% ▲ 1.20% Aug 31, 2026
6 Lord Abbett Value Opportunities I 342.44K 0.84% ▼ 0.39% Aug 31, 2026
7 Oberweis Micro-Cap 300.20K 0.74% ▲ 12.94% Jun 30, 2026
8 Fidelity Small Cap Growth 289.73K 0.71% ▲ 0.00% Jul 31, 2026
9 Nuveen Quant Small Cap Equity R6 241.37K 0.59% ▲ 0.00% Aug 31, 2026
10 Fidelity Small Cap Index 229.69K 0.57% ▲ 0.98% Jul 31, 2026

Financial Highlights

▼
Market Cap: $1.58B
EBITDA: $244.23M
P/E Ratio: $15.99
PEG Ratio: $1.68
Book Value: $9.50
Dividend/Share: $0.48
Dividend Yield: 1.27%
Earnings/Share: $2.43
Profit Margin: 6.57%
Operating Margin: 10.64%
ROA (TTM): 8.48%
ROE (TTM): 29.72%
Revenue (TTM): $1.52B
Revenue/Share (TTM): $37.44
Earnings Growth (YOY): 24.60%
Revenue Growth (YOY): 4.80%

Valuation Metrics

Enterprise Value: $2.24B
Trailing P/E: 15.99
Forward P/E: 13.83

Shares Statistics

Shares Outstanding: 21.11M
Shares Float: 20.91M
% Insiders: 0.878%
% Institutions: 102.78%
Shares Short: 1.03M
Shares Short (Prior Month): 1.02M
Short Ratio: 4.10
Short % Float: 7.09%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$1.52B
Cost of Goods Sold
adjust
$-1.01B
Gross Profit
subtotal
$511.71M
SG&A
adjust
$-312.50M
Operating Income
subtotal
$198.44M
Other / Non-Operating Items
adjust
$-98.72M
Net Income
subtotal
$99.72M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PAHC.US!